Sponsors

Hepatitis C virus immunoassay

Roche Diagnostics has announced that the Elecsys anti-hepatitis C virus (HCV) assay has received regulatory approval in Europe for the E170 analyser for modular analytics and the e601 module for the Cobas 6000 platform. The Elecsys anti-HCV assay is already available on the Elecsys 2010 and the Cobas e411 instruments.

Hepatitis C virus infection represents a major cause of death through the development of severe fibrosis, cirrhosis and liver cancer. The principal mode of transmission is parenteral exposure to infected blood or blood products (ie insufficient blood screening procedures, mainly in developing countries) and contaminated needles or other invasive medical tools.

Roche
www.roche.com

Latest Issues

RSM / Path Soc 2026 Winter Meeting

The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

USCAP 115th Annual Meeting

Henry B. González Convention Center, San Antonio, Texas, USA
21 - 26 March, 2026